Dr. Kanter: I wouldn’t recommend it

Assistant State Health Officer weighs in on President Trump's Hydroxychloroquine comment

Kenny Kuhn
May 22, 2020 - 11:15 pm
USA TODAY

Sipa USA

President Donald Trump has stirred backlash when he said during a press conference earlier this week, that he will be finishing a regimen treatment of Hydroxychloroquine to prevent contracting COVID-19.

Hydroxychloroquine also goes by the brand name Plaquenil. It is commonly used as a prophylaxis against malaria.

However, President Trump’s comments about taking the controversial drug, come as a recent study published in the journal Lancet finds no evidence the drug prevents coronavirus. The study in fact suggests taking the drug is quite dangerous as it has shown in the study.

Assistant State Health Officer with the Louisiana Department of Health, Dr. Joseph Kanter told Newell Normand on his show Thursday, that taking the drug could damage the hearts rhythm.

“Statistically, if you take it you are more likely to have an adverse cardiovascular event… it gives you arrhythmias… then you are to actually prevent exasperation of COVID, and that is even for people who have COVID. There is even less data on preventing COVID in the first place which I assume is the reason he is taking it in the first place,” Dr. Kanter explained on Newell’s show.

Dr. Kanter says Hydroxychloroquine hasn’t shown in studies to have any benefits at all in preventing COVID-19.

“When you have any intervention that has a known side effect, arrhythmias which could potentially be fatal, you got to weigh that known downside a known upside and at this point, there really isn’t a good known upside so you are just left with the downside which is not a good place to be,” said Kanter. “I wouldn’t recommend it and most of my colleagues would not either.”

The U.S. Food and Drug Administration says it is aware of reports of serious heart rhythm problems in COVID-19 patients taking Hydroxychloroquine and warns against patients taking it outside a hospital setting.

 

Comments ()